R. Maher

发表

FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.

J. Fay, H. Deeg, K. Sullivan, 1996, Blood.

Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis.

I. Bekersky, W. Fitzsimmons, I. Lawrence, 2001, Journal of the American Academy of Dermatology.

Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation.

J. Fay, J. Wingard, R. Nash, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

A. Deisseroth, K. Cleary, H. Fritsche, 1996, Blood.

Tacrolimus and Minidose Methotrexate for Prevention of Acute Graft- Versus-Host Disease After Matched Unrelated Donor Marrow Transplantation

A. Deisseroth, K. Cleary, B. Andersson, 1996 .

The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis.

K. Beusterien, L. Drake, N. Korman, 2001, Journal of the American Academy of Dermatology.

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

R. Collins, J. Fay, J. Wingard, 1996, Blood.

FK 506 ( Tacrolimus ) Monotherapy for Prevention of Graft-Versus-Host Disease After Histocompatible Sibling Allogeneic Bone Marrow Transplantation

R. Collins, J. Fay, J. Wingard, 2002 .

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections.

A. Fleischer, L. Eichenfield, M. Rico, 2002, Journal of the American Academy of Dermatology.

Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.

R A Nash, J. Fay, J. Wingard, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.

M. Horowitz, J. Wingard, W. Fitzsimmons, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

A. Nademanee, J. Fay, R. Storb, 1998, Blood.

Tacrolimus pharmacokinetics in BMT patients

J. Fay, J. Wingard, R. Nash, 1998, Bone Marrow Transplantation.

Phase III Study Comparing Methotrexate and Tacrolimus ( Prograf , FK 506 ) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

A. Nademanee, J. Fay, R. Storb, 1998 .

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients

J. Fay, J. Wingard, S. Devine, 1997, Bone Marrow Transplantation.

The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.

J. Wingard, S. Dix, H. Holland, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.